MUlti-center Registry exAmining synergy everoliMus bioAbsorbable polymer Stent in coronary intervention of complex Arterial lesion subsets registry
Not Applicable
Recruiting
- Conditions
- Complex coronary artery disease
- Registration Number
- JPRN-UMIN000027378
- Lead Sponsor
- Treatment of complex coronary lesion research society
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Not provided
Exclusion Criteria
1) Hypersensitivity to cobalt chromium, everolimus, heparin, aspirin, ticlopidine, clopidogrel or X-ray contrast media. 2) Serum creatinine level >3.0 mg/dL 3) Other concomitant disease or medical condition that could impact patient/procedural outcomes, such as history of bleeding diathesis or cancer within 5 years.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major adverse cardiac event including cardiac death, myocardial infarction, and target vessel revascularization at 12 month.
- Secondary Outcome Measures
Name Time Method a.Procedural success b.Target lesion revascularization at 12 month c.TVR at 12 month d.MI at 24 month e.Death at 24 month f.MACE at 24 month g.Stent thrombosis (acute, sub-acute, late,and very late) definited by Academic Research Consortium (ARC) at 24 month